Education
About Us
Working with TipRanks
Follow Us
Quantum Genomics (QNNTF)
OTHER OTC:QNNTF
Total Valuation
Quantum Genomics has a market cap or net worth of $5.79M. The enterprise value is $49.61M.
Market Cap$5.79M
Enterprise Value$49.61M
Share Statistics
Quantum Genomics has 69,709,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding69,709,950
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Quantum Genomics’s return on equity (ROE) is -7.26 and return on invested capital (ROIC) is -98.42%.
Return on Equity (ROE)-7.26
Return on Assets (ROA)-0.85
Return on Invested Capital (ROIC)-98.42%
Return on Capital Employed (ROCE)-1.31
Revenue Per Employee6.60K
Profits Per Employee-1.06M
Employee Count3
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Quantum Genomics is -1.17. Quantum Genomics’s PEG ratio is -0.01.
PE Ratio-1.17
PS Ratio0.00
PB Ratio1.13
Price to Fair Value8.46
Price to FCF-0.20
Price to Operating Cash Flow-0.20
PEG Ratio-0.01
Income Statement
In the last 12 months, Quantum Genomics had revenue of 19.80K and earned -3.17M in profits. Earnings per share was -0.09.
Revenue19.80K
Gross Profit-1.42M
Operating Income-3.14M
Pretax Income-3.21M
Net Income-3.17M
EBITDA-2.87M
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was -7.64M and capital expenditures 0.00, giving a free cash flow of -7.64M billion.
Operating Cash Flow-7.64M
Free Cash Flow-7.64M
Free Cash Flow per Share-0.11
Dividends & Yields
Quantum Genomics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.18
52-Week Price Change0.00%
50-Day Moving Average0.10
200-Day Moving Average0.10
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Quantum Genomics upcoming earnings date is Mar 28, 2024, TBA Not Confirmed.
Last Earnings DateOct 5, 2023
Next Earnings DateMar 28, 2024
Ex-Dividend Date―
Financial Position
Quantum Genomics as a current ratio of 2.73, with Debt / Equity ratio of 84.09%
Current Ratio2.73
Quick Ratio2.73
Debt to Market Cap0.74
Net Debt to EBITDA0.29
Interest Coverage Ratio-146.59
Taxes
In the past 12 months, Quantum Genomics has paid -34.43K in taxes.
Income Tax-34.43K
Effective Tax Rate0.01
Enterprise Valuation
Quantum Genomics EV to EBITDA ratio is -1.00, with an EV/FCF ratio of 0.00.
EV to Sales144.69
EV to EBITDA-1.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Quantum Genomics has $3.55M in cash and marketable securities with €2.72M in debt, giving a net cash position of -$830.55K billion.
Cash & Marketable Securities$3.55M
Total Debt€2.72M
Net Cash-$830.55K
Net Cash Per Share-$0.01
Tangible Book Value Per Share$0.01
Margins
Gross margin is -1073.02%, with operating margin of -15847.92%, and net profit margin of -16018.12%.
Gross Margin-1073.02%
Operating Margin-15847.92%
Pretax Margin-16192.05%
Net Profit Margin-16018.12%
EBITDA Margin-14515.46%
EBIT Margin-15847.91%
Analyst Forecast
The average price target for Quantum Genomics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―